## Critical Evaluation
### Key Weaknesses
**Anatomical premise concerns**: The hypothesis targets EC layer II SST interneurons, but EC layer II is predominantly composed of stellate cells (projection neurons) and grid cells. SST interneurons, while present, constitute a relatively sparse population compared to parvalbumin (PV+) basket cells, which are the canonical drivers of gamma oscillations. The theoretical analysis cites Buzsáki's work on gamma mechanisms, which primarily implicates PV-Pyramidal feedback loops, not SST circuits. The mechanistic attribution to SST may conflate correlative observations with causal drivers.
**Cell-type specificity mechanism undefined**: FUS neuromodulation is not inherently cell-type selective. The analysis assumes selective SST+ activation but provides no mechanism explaining how 40 Hz FUS would preferentially engage SST neurons over pyramidal cells or PV interneurons within the sonicated volume. This critical gap undermines the entire anatomical precision claim.
### Missing Evidence
1. Direct causal evidence that SST dysfunction *drives* tau propagation, rather than representing an epiphenomenon of network dysfunction
2. Proof-of-concept data demonstrating FUS can selectively activate SST interneurons in EC
3. Validated closed-loop biomarker for real-time gamma detection (the analysis acknowledges this limitation but doesn't propose solutions)
4. Empirical support for the gamma-glymphatic link specifically in EC circuitry
### Alternative Explanations
The Iaccarino et al. framework the hypothesis extends implicated **microglia-mediated** mechanisms as essential mediators of gamma entrainment effects. Behavioral improvement may result from non-specific network effects, BBB modulation, or widespread neuroinflammatory changes rather than EC-II SST targeting. Furthermore, EC-hippocampal communication restoration may achieve therapeutic effects through general circuit normalization, not SST-specific mechanisms.
### Methodological Challenges
Precise EC layer II targeting in behaving animals presents substantial technical hurdles. c-fos provides indirect, delayed activation readouts unsuitable for closed-loop validation. Tau propagation experiments require long-term longitudinal imaging given the slow progression of pathology. Additionally, the 3xTg and P301S models exhibit amyloid and tau pathologies respectively, but neither fully recapitulates human AD spatiotemporal patterning, limiting translational relevance.